WellSpan Health announced today that WellSpan Oncology Services and Cancer Care Associates of York are the first in the United States selected to participate in an international research study to test the effectiveness of a specific drug combination to treat breast cancer. ” said Douglas Arbittier, M.D., vice president of WellSpan’s Oncology Service Line.